SCHEMBL21977968

SCHEMBL21977968

O=CC(OCc1ccccc1)C(OCc1ccccc1)C(CO)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.42
SLC1A2 P43004 2/20 0.42
SLC1A1 P43005 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 3/20 0.38
MAPT P10636 1/20 0.36
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCND1 P24385 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
TSHR P16473 2/20 0.34
HCAR2 Q8TDS4 1/20 0.34
SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10508541 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL1561040 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10507160 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10507624 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10510294 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL1561755 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10507314 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10509040 1.00 SLC1A3 (0.42) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL10510640 0.95 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL5435410 0.95 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115281-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECH INC (US) 2026-04-30 US disclosed
US-12569554-B2 Triterpene saponin analogues ADJUVANCE TECHNOLOGIES, INC. (US) 2026-03-10 US disclosed
US-20240327443-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECHNOLOGIES, INC. (US) 2024-10-03 US disclosed
US-20230219991-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECHNOLOGIES, INC. (US) 2023-07-13 US disclosed
CN-112812143-A Triterpene saponin analogues 佐剂技术公司 2021-05-18 CN disclosed
CN-108778289-B Triterpene saponin analogues 佐剂技术公司 2020-11-17 CN disclosed
US-20200164065-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECHNOLOGIES, INC. (US) 2020-05-28 US disclosed
CN-110730666-A Triterpene saponin analogues 佐剂技术公司 2020-01-24 CN disclosed
CN-110582282-A Triterpene saponin analogues 佐剂技术公司 2019-12-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219991-A1 TRITERPENE SAPONIN ANALOGUES LSS, NFATC1, PGGT1B SLC1A3 4688/4885SLC1A2 4783/4885SLC1A1 4761/4885
US-20240327443-A1 TRITERPENE SAPONIN ANALOGUES LSS, NFATC1, PGGT1B SLC1A3 4688/4885SLC1A2 4783/4885SLC1A1 4761/4885
US-12569554-B2 Triterpene saponin analogues TLR4, TLR7, TLR8 SLC1A3 3625/4885SLC1A2 4423/4885SLC1A1 3995/4885
US-20200164065-A1 TRITERPENE SAPONIN ANALOGUES LSS, NFATC1, PGGT1B SLC1A3 4688/4885SLC1A2 4783/4885SLC1A1 4761/4885
US-20260115281-A1 TRITERPENE SAPONIN ANALOGUES NR1H2, NR1H3, LSS SLC1A3 4731/4885SLC1A2 4760/4885SLC1A1 4752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.